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AIM OF STUDY 
 
 
This study evaluates the effectiveness and safety of two strategies, 
Pressure support ventilation (PSV) and T piece ventilation for weaning 
adult patients who require elective post operative mechanical ventilation 
for at least 12 hours, measuring weaning success and other clinically 
important outcomes. 
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INTRODUCTION 
 Ventilator is a simple machine designed to apply & transmit energy 
which serves to perform useful work, following a set scheme.  
 Three pressures that determine the flow and, therefore, the 
generation of volume; these are: 
1. The atmospheric pressure (Patm) 
      2. The alveolar pressure, the pressure within the lungs (Palv); 
3. The pleural pressure, the pressure generated between the lungs 
and the thoracic cage (Ppl).  
Pressure Gradient 
 The movement of air from outside the body to the lungs and vice 
versa is made by a pressure gradient between the exterior (Patm) and 
interior of the lungs (Palv). 
  If the Palv decreases with respect to the Patm, it is of negative 
pressure ventilation.  
 If the Patm (pressure at the mouth) increases with respect to the Palv, 
it is of positive pressure ventilation  
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 Trans-respiratory system pressure is the pressure at the airway 
opening minus pressure at the body surface. 
Pressure driving inspiration 
 Transairway pressure-airway opening pressure minus lung pressure 
 Transthoracic pressure – lung pressure minus body surface 
pressure. 
 Transpulmonary pressure –airway opening pressure minus pleural 
pressure  
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Baromatric Pressure (PB) & Alveolar Pressure (Palv) during 
Spontaneous Breathing 
Spontaneous 
Breathing 
PB(cm H2O) PALV(cmH2O) P Flow 
Inspiration 0 -5 -5 Into the 
Lungs 
End of 
Inspiration 
0 0 0 None 
Expiration 0 20 -20 Out of lungs 
End of 
Expiration 
0 0 0 Nil Flow 
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Inspiratory Pressure (Pi) & Alveolar Pressure (Palv) during PPV 
Positive 
Pressure 
Ventilation 
Pi(cm H2O) PALV(cmH2O) P Flow 
Inspiration 20 0 +20 Into the 
Lungs 
End of 
Inspiration 
20 20 0 Nil Flow 
Expiration 0 20 -20 Out of lungs 
End of 
Expiration 
0 0 0 Nil Flow 
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DURING POSITIVE PRESSURE VENTILATION 
 
Comparison of volume control using constant inspiratory flow with 
pressure control using constant inspiratory pressure. Shaded areas 
show pressure due to resistance. Unshaded areas show pressure due 
to compliance. 
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COMPLIANCE 
 Volume change  per unit pressure change C = ∆V/ ∆P. 
 Static Compliance - measured when the flow is momentarily 
stopped 
 Dynamic Compliance -Dynamic compliance is measured when 
airflow is present. 
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Compliance Conditions 
Static Compliance Tension Pneumothorax  
Obesity  
ARDS 
Retained secretions 
Atelectasis 
Dynamic Compliance Bronchospasm 
Airway obstruction 
ET tube Kinking  
 
AIRWAY RESISTANCE (R) 
 Airway resistance is defined as impedence offered to the flow of 
gas or fluid through a tube (ET tube or  conducting  airways) 
 Affected by the size, Length(L), radius (r) and patency of the 
airway, endotracheal tube, and ventilator circuit 
 R = L/r4 
 Hypoventilation occurs if the patient is can’t overcome the airway 
resistance by increasing the work of breathing 
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Type Conditions 
COPD Emphysema 
Asthma 
Bronchiectasis 
Chronic bronchitis 
Mechanical obstruction Foreign body aspiration 
Post intubation obstruction 
Condensation in ventilator circuit 
Endotracheal tube 
Infection Layngotracheobronchitis (croup) 
Bronchiolitis 
Epiglottitis 
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MECHANICAL VENTILATION 
Calculating mean airway pressure 
Peak inspiratory pressure:  
The pressure used to deliver the tidal volume by overcoming 
elastic lung parenchyma and nonelastic airways resistance 
Plateau Pressure:  
The pressure needed to maintain lung in inflated state in the 
absence of airflow for diffusion of gases. 
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Equation for motion of the respiratory system 
 Pvent + Pmusc = Elastance x Volume + (Resistance x Flow) 
During inspiration 
 Variables - Pressure, volume, and flow 
 Parameters- Elastance and resistance 
 Flow  = Volume  / Time   
During expiration 
 Passive process 
 Resistance x Flow = Elastance  xVolume. 
 Minus sign at the left of the equation indicates the negative 
direction of the expiratory flow 
 Elastance = ∆Pressure/ ∆Volume 
 Resistance = ∆pressure/ ∆flow 
 Muscle pressure+ vent pressure= elastic load+ resistive load 
 Elastic load is the pressure required to deliver the tidal volume. 
 Resistive load is the pressure required to deliver the flow 
 Compliance =volume/pressure= 1/ elastance  
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MODES OF VENTILATION 
A mode is a description of  
1. How the ventilator is triggered or initiated into inspiration. 
2. How it is cycled to expiration. 
3. What variables or parameters are limited during inspiration 
4. Whether the mode allows mandatory, spontaneous or assisted breath. 
COMPONENTS OF A MODE 
1. Breath types 
2. Phase variables 
3. Control variables 
BREATH TYPES 
 Mandatory breath  
Started and ended by machine 
 Assisted breath 
Started by the patient but ended by the machine 
 Spontaneous Breath 
Started and ended by the patient 
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PHASE VARIABLES 
• It refers to the four phases of  a breath 
• Change from expiration to inspiration - TRIGGER 
• During inspiration – LIMIT 
• Change from inspiration to expiration – CYCLE 
• Expiration - BASELINE  
 
TRIGGER 
Initiates the breath 
TIME TRIGGER 
Ventilator initiates breath according to set frequency, independent of 
patient efforts( CMV) 
PRESSURE TRIGGER 
Ventilator senses the decrease in baseline pressure, independent of set 
frequency 
FLOW TRIGGER 
Ventilator senses the decrease in return flow through the circuit  
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LIMIT 
• A variable (pressure/volume/flow) which is limited during 
inspiration 
• IT DOES NOT TERMINATE INSPIRATION 
 
 
CYCLE 
• It terminates inspiration and switch over to expiration 
• It could be time, pressure, volume or flow 
BASELINE 
Variable that is controlled during the expiratory time (Pressure) 
If the pressure is held higher than ambient pressure, it is called PEEP  
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CONTROL VARIABLE 
• Denotes which (parameter)  variable  we are going to set/control 
• VOLUME 
• PRESSURE 
• TIME 
  If the variable / parameter eg: volume is controlled then that 
remains constant and the other variable/ parameters may vary.  
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MECHANICAL VENTILATOR
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CLASSIFICATION OF CONVENTIONAL MODES 
Conventional modes are classified into 2 types based on the two 
components of a mode. 
1. Based on type of breath  
2. Based on control  variables 
 
BASED ON TYPE OF BREATH 
 CMV – CONTINUOUS MANDATORY                
 VENTILATION 
 IMV- INTERMITTENT MANDATORY   
 VENTILATION 
 SIMV- SYNCHRONOUS INTERMITTENT  
 MANDATORY VENTILATION 
BASED ON CONTROL VARIABLES MODES  ARE CLASSIFIED  
1. Pressure control  or pressure preset 
2. Volume control or volume preset. 
Example: 
If the volume is controlled then the pressure may vary depending on the 
compliance of the lung. 
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VOLUME CONTROL 
ADVANTAGES 
•        Guaranteed tidal volume 
•        Less chance of atelectasis  
DISADVANTAGES 
• Limited flow available may not meet patient’s desired flow rate. 
• Can cause excessive airway pressure (BAROTRAUMA)  
PRESSURE CONTROL 
The pressure gradient created between the proximal airway and the distal 
alveoli drives the tidal volume in to the lungs 
ADVANTAGES 
• Constant Peak airway pressure is maintained 
• Improves gas distribution 
• Lowers Work of  breathing 
DISADVANTAGES 
• Variable Tidal Volume  
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VOLUME VERSUS PRESSURE CONTROL MODE 
VENTILATION 
Volume Ventilation Pressure Ventilation 
Volume delivery constant Volume delivery varies  
Inspiratory pressure varies Inspiratory pressure constant 
Inspiratory flow constant  Inspiratory flow varies 
Inspiratory time determined by set 
flow  and Tidal Volume  
Inspiratory time set by clinician  
 
Controlled Mandatory Ventilation (CMV) 
 In this mode, the ventilator delivers a preset tidal volume at a time-
triggered respiratory rate. 
 It control the patient’s minute ventilation. 
 Requires Sedatives and neuromuscular blockers. 
 Mandatory breath – ventilator determines the start time (time 
triggered) and/or the volume or pressure limited 
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Controlled Mandatory Ventilation (CMV/VCV) 
Appropriate when a patient can make no effort to breathe or when 
ventilation must be completely controlled  
 Spinal cord injury 
 Cerebral malfunctions 
 Motor nerve paralysis 
 Phrenic nerve injury 
 Controlled ventilation is difficult to use unless the patient is 
sedated or paralyzed with medications 
• Intra  operative controlled ventilation 
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• Seizure activity 
• Tetanic contractions 
• Complete rest for the patient 
• Crushed chest injury – stabilizes the chest 
The primary hazard associated with control mode is potential for 
apnea and hypoxia if patient have accidentally disconnected from 
ventilator or ventilator failed to operate 
ASSIST CONTROL MODE (ACMV) 
• In this mode, the mandatory breaths may be either patient 
triggered (assist) or time triggered by a preset respiratory rate 
(control). 
•   Minute ventilation can be increased by patient. 
•  Useful in pts with stable respiratory drive.  Trigger level should be 
appropriate 
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MODE INITIATE CONTROL CYCLE 
VOLUME 
ACMV 
PATIENT OR TIME VOLUME FLOW OR 
VOLUME 
PRESSURE 
ACMV 
PATIENT OR TIME PRESSURE TIME 
 
INDICATIONS 
• This mode of ventilation is often used to provide full ventilatory 
support for patients when they are first placed on mechanical 
ventilation. 
 24 
 
•  Typically used for patients who have stable respiratory drive and 
average Respiratory Rate and  can therefore trigger .  
• Advantages 
• Decreases the work of breathing  
• Allows patients to regulate respiratory rate 
• Complications 
• Alveolar hyperventilation 
• TRIGGER – time / patient 
• LIMIT- volume / pressure 
• CYCLE- volume / time 
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INTERMITTENT MANDATORY VENTILATION 
 Mandatory breath (volume or pressure targeted breaths) 
occur at set interval (time triggering) 
 Between mandatory breaths, the patient breathes 
spontaneously at any desired baseline pressure without 
receiving a mandatory breath 
 Mechanical rate and spontaneous rate may become 
asynchronous causing “stacking” 
 May cause barotrauma or volutrauma  
 
 
SYNCHRONISED IMV (SIMV) 
• The patient receives the Mandatory set Volume at set Respiratory 
Rate 
• The set Mandatory breaths are synchronized with patient efforts. 
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• Between the mandatory breaths the patient can breath 
spontaneously  
 Triggering   -  Time or patient 
     Limiting       -   Volume / pressure 
     Cycling        -   Volume / time 
 
SYNCHRONISATION / TIMING WINDOW 
• The time interval just prior to time triggering in which ventilator is 
responsive to patient’s spontaneous inspiratory effort is known as 
synchronisation window. 
•  Time interval of 0.5s is representative. 
•  If patient makes a spontaneous inspiratory effort when 
synchronisation window is active, ventilator will deliver an assisted 
patient triggered breath  
 27 
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Indications 
• Facilitate transition from full ventilatory support to partial 
support 
• Advantages 
• Decreases mean airway pressure 
• Facilitates ventilator discontinuation – “weaning” 
• Maintains respiratory muscle strength by avoiding muscle 
atrophy 
COMPLICATIONS 
• Desire to wean the patient too rapidly may lead to high work  of 
spontaneous breathing leading to muscle fatigue and weaning . 
• The best way to avoid this is to decrease SIMV mandatory 
respiratory rate slowly and monitor the patient closely for signs of 
fatigue.   
PRESSURE SUPPORT VENTILATION (PSV) 
• The ventilator provides a constant pressure during inspiration 
once it senses that the patient has made an inspiratory effort 
• Pressure supported breath are considered spontaneous  
• Patient triggered 
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• Tidal Volume varies with patient’s inspiratory flow demand 
• Inspiration last only for as long as the patient actively inspires 
• Inspiration is terminated when inspiratory flow demand reaches the 
preset value  
• Trigger – Patient 
• Limit – Pressure 
• Cycle – flow  
ADVANTAGES 
• Augments the patients spontaneous Tidal Volume 
• Decreases patient Work of Breathing by overcoming the 
resistance of the artificial airway, vent circuit and demand valves 
• Prevents respiratory muscle atrophy 
• Facilitates weaning 
• Improves patient comfort and reduces need for sedation 
• May be applied in any mode that allows spontaneous breathing, 
e.g., VC-SIMV, PC-SIMV 
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Disadvantages 
 Requires consistent spontaneous ventilation 
 Patients in stand-alone mode should have back-up ventilation 
 Tidal Volume variable and dependant on lung characteristics 
and synchrony 
 Fatigue and tachypnea if Pressure Support level is set too low 
 
SIMV WITH Pressure Support 
 Pressure support is commonly applied in SIMV mode when 
patient take spontaneous breaths. 
 To facilitate weaning in a difficult to wean patient. 
In this mode, pressure support 
 Increase patient’s spontaneous Tidal Volume 
 Decrease patient’s spontaneous Respiratory Rate 
          decreases the work of breathing 
 31 
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PEEP 
• Pressure above ambient at the end of expiration  
• Not a stand alone Mode 
Indications:  
• Intrapulmonary shunt & refractory hypoxemia,  
• Decreased FRC and lung compliance 
• Auto PEEP 
• Helps prevent early airway closure and alveolar collapse and 
the end of expiration by increasing (and normalizing) the 
functional residual capacity (FRC) of the lungs 
• Facilitates better oxygenation 
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PEEP is intended to improve oxygenation, not to provide ventilation, 
which is the movement of air into the lungs followed by exhalation 
Complications 
• Decreased Venous return & Cardiac output 
• Barotrauma  
• Increased ICT 
• Decreased Renal perfusion 
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CPAP 
It is PEEP applied to the airway of the Spontaneously breathing patients 
• Helpful for improving oxygenation in patients with refractory 
hypoxemia and a low FRC 
• CPAP setting is adjusted to provide the best oxygenation with the 
lowest positive pressure and the lowest FiO2 
• Advantages 
• Ventilator can monitor the patient’s breathing and activate an alarm 
if something undesirable occurs 
 
 
Pressure remains positive and do not return to zero baseline  
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 CMV - all breaths are mandatory 
 ACMV - two types of breath, assisted and mandatory as back 
up.  
 IMV - TWO types of breath ,mandatory and spontanous. 
  SIMV - 3 types of breath- mandatory , assisted and 
spontanous. 
  Spontaneous (CPAP/BiPAP) - all breaths are spontaneous 
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WEANING FROM MECHANICAL VENTILATION 
 
 WEANING SUCCESS 
 WEANING IN PROGRESS 
 WEANING FAILURE  
 
VENTILATORY CRITERIA 
 PaCo2 -<50 mm Hg 
 Vital capacity ( >10 ml/kg) and spontaneous tidal volume 
( >5 ml / kg) 
 Spontaneous frequency - <35 / min 
 f/Vt - >105 breaths/min/L 
 Minute ventilation - <10 L  
Oxygenation criteria 
 PaO2 - ( >60 or >100 mm Hg) 
 SaO2 > 90 % 
 PaO2 / FiO2 - >200 mm Hg 
 Qs / Qt - <20 % 
 P(A –a )O2 - <350 mm Hg  
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Pulmonary reserve and Pulmonary Measurements 
 Static compliance  
 = ∆ V / ∆ P- 30 ml /cm H20 
 Airway resistance (0.6 – 2.4 cm  H20 ) 
 Dead space / tidal volume Ratio 
 VD/ VT = (PaCo2 – PECo2)/ PaCo2 
 Should be <60 % 
Rapid Shallow Breathing Index 
 Spont. Breathing frequency /spon.tidal volume 
 >100 breaths/ lit /min – weaning failure 
 < 100 Breaths/Lit/min – weaning success  
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Category Example Note 
Clinical Criteria 
Resolution of acute phase of 
disease 
Absence of excessive 
secretions 
Adequate cough 
Cardiovascular and 
hemodynamic stability 
 
Ventilatory 
Criteria 
Spontaneous breathing trial Tolerate 20 to 30 min 
Vital capacity >10 mL/kg 
PaCO2 <50 mm Hg with 
normal pH 
Spontaneous Tidal volume >5 ml/Kg 
Spontaneous Resp. rate <35/min 
TV/RR <100 breaths/min/Lit* 
Minute Volume <10 L with good ABG 
Oxygenation 
Criteria 
PaO2 without PEEP >60 mm Hg at 
FiO2<40% 
PaO2 with PEEP 
 (≤8 cm H2O) 
>100 mm Hg at 
FiO2<40% 
 PaO2/FiO2 (PF Ratio) ≥150 mm Hg 
Pulmonary 
Measurements 
Airway resistance Stable or improving 
Static compliance >30 ml / cm H2O 
VD/VT <60% with ET tube 
Pulmonary 
reserve 
Max. Insp. pressure > -30 cm H2O in 20 
sec 
 Vital capacity  
 
>10 ml/kg  
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WEANING PROCEDURE 
 
SPONTANEOUS BRAETHING TRIAL 
                                 
CPAP –PSV or T – Piece 
                                 
Spontaneous Breating for 90 min 
 
                                 
PSV up to 8 cm H2O in CPAP   T-Piece 
                                 
Assess the pt 
                                 
Extubate if ABG normal 
 40 
 
SIMV 
 
Reduce the frequency by 1 – 3 breaths / min 
                             
MONITOR SpO2 
                                     
Reduce it further until a frequency of 2 – 4 
                                      
Extubate if ABG NORMAL 
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PRESSURE SUPPORT VENTILATION 
 
Decrease the airflow resistance 
                           
Spontaneous breathing must 
                    
Start with   15 cm H2O ( MAX -40) 
                       
Decrease by 3 to 6 cm H2O up to 8cm H2O 
                        
EXTUBATE if ABG normal. 
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MONITORING IN MECHANICAL VENTILATION 
 
Monitoring patient's clinical condition 
• Important because clinical status changes rapidly and 
unpredictably. 
• Parameters monitored 
• Vital signs 
• Chest inspection, auscultation 
• Fluid balance & anion gap 
• ABG 
 Non-invasive monitoring 
 Monitoring Heart Rate 
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Tachycardia : 
 Hypovolemia 
 Hypoxemia 
 Anxiety and stress 
 Shock 
 Fever 
 Pain 
Bradycardia : 
 Suctioning 
 Drug reaction (morphine) 
 Hypoxia 
 Heart block 
 Inadequate coronary blood flow 
 Hypothermia 
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Monitoring  blood pressure 
Hypertension 
 Stress 
 Anxiety 
 Pain 
 Drugs (adrenaline) 
 Polycythemia 
 Fluid over load 
  Hypotension 
 ↓venous return due to PPV 
 Absolute hypovolemia 
 Septic shock 
 Myocardial depression 
 Pneumothorax 
Monitoring respiratory rate 
• Pain 
• Anxiety 
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• Shock 
• Tension pneumothorax 
• Fever 
• Tube displacement, block 
• Inappropriate settings  
ABG 
 1 hr after starting ventilation 
  After change of settings 
  Fall in saturation or clinical worsening 
  Pre and post weaning 
 ETCO2 &Spo2 monitoring reduces need for ABG 
VENTILATION: 
•    hypoventilation & respiratory acidosis    
•    hyperventilation & respiratory alkalosis 
OXYGENATION:  assessed by  PaO2, P(A-a) O2,   
                         PaO2/PA O2, PaO2/FiO2   
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                   INTERPRETATION OF OXYGENATION STATUS  
PARAMETERS CRITERIA 
PaO2  80-100 mm Hg   :normal  
 60-79 mm Hg      :mild hypoxemia  
 40-59  mm Hg     :moderate 
hypoxemia  
 <40   mm Hg        :severe 
hypoxemia  
PaO2/FiO2 <300 mm Hg        :ALI  
 <200 mm Hg        :ARDS  
P(A-a)O2  5-10 mm Hg         : normal  
PaO2/PA O2  >75%                     : normal  
 <75%                     :hypoxemia  
 
Non invasive monitoring 
• ET CO2  
• ECG 
• NIBP 
• SpO2 
• TEMPERATURE 
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MONITORING ETCO2 
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REVIEW OF LITERATURE 
 
1) Ely et al (1994) showed that immediate extubation after successful 
trials of spontaneous breathing expedites weaning and reduces the 
duration of mechanical ventilation as compared with a more 
gradual discontinuation of ventilatory support. 
2)  Brochard et al(1994)  Showed  there was no difference in the 
duration of weaning between the T-piece and SIMV groups, but 
PSV led to significantly shorter duration of weaning compared 
with the combined T-piece and SIMV cohorts (5.7±3.7 days versus 
9.3±8.2 days). 
3) Esteban et al (1995) showed (76%) patients were successfully 
extubated on their first day of weaning after a T-piece trial. The 
24% patients who failed were randomized to undergo weaning by 
the following strategies: once a day T-piece trial; two or more T-
piece or continuous positive airway pressure trials each day as 
tolerated; PSV with attempts at reduction of 2–4 cmH2O at least 
twice a day; and SIMV with attempts at reduction by two to four 
breaths/min at least twice a day. Patients assigned to the four 
groups. The weaning success rate was significantly better with 
once daily and multiple T-trials than with PSV and SIMV. PSV 
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was not superior to SIMV. The median duration of weaning was 5 
days for SIMV, 4 days for PSV and 3 days for the T-piece 
regimens. The studies by Brochard et al  and Esteban et al yielded 
two important common conclusions: first, the pace of weaning 
depends on the manner in which the technique is applied; and 
second, that SIMV is the least efficient technique of weaning. With 
respect to PSV and intermittent trials of T-tube, a clear superiority 
of one technique over the other has not yet been established.. 
4) Matic et al (2004) studied  T-tube and pressure support ventilation 
(PSV) as two methods of weaning patients from mechanical 
ventilation. PSV was the superior method of weaning according to 
rate of successful extubation, time of weaning from mechanical 
ventilation, total time of mechanical ventilation, and length of 
hospital stay 
5)  Koh et al studied 42 weaning trials in 36 patients with respiratory        
failure requiring at least three days of mechanical ventilation in a 
medical ICU. All patients were intubated with an 8-mm 
endotracheal tube and managed using pressure controlled 
ventilation. When the primary disease process was judged to be 
improved and oxygenation was adequate on FiO2 = 0.5, PEEP less 
than 6 cm H2O, patients were switched to 15 cm H2O PSV and 
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weaned to minimal pressure support (PSmin) as quickly as possible 
(3-5 cm H2O per hour). PSmin was determined as peak flow rate 
(during spontaneous ventilation) x total respiratory system 
resistance on the ventilator without positive pressure. Total 
resistance was determined during a controlled breath. When 
patients were weaned to this level, they were randomized to be 
either extubated immediately or placed on an additional hour of T-
piece breathing. If they showed signs of respiratory distress or 
decline in gas exchange, weaning failure was diagnosed. If this was 
following T-piece trial, extubation was delayed until they 
successfully completed the trial. 
Weaning failure occurred 16 times in 14 patients out of the 42 
trials performed. Therefore, 70% of the immediate extubation 
group remained extubated while only 55% of the T-piece group 
was able to complete the trial and remain extubated. This 
difference, however, was not statistically different. Patients who 
failed one method were crossed over for weaning and about half 
were successfully weaned using the other method. Two patients 
failed by both methods. Reintubation rates in the initially 
successful patients were identical in the two groups, 18% in the T-
piece and 20% in the PSV group; noninvasive ventilation was used 
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in four patients to avoid reintubation. Prior to weaning, respiratory 
indices were not different, including: tidal volume, respiratory rate, 
minute ventilation, rapid shallow breathing index (spontaneous 
respiratory rate divided by average tidal volume), work of 
breathing, respiratory drive, and duration of ventilation (> 10 
days). Patients were older (65 vs 55 years) in the T-piece group, 
had slightly higher albumin level (3.0 vs 2.7 mg%), and lower 
APACHE II scores (33 vs 38). However, none of these differences 
were reported as statistically significant. (Koh Y, et al. J Crit 
Care 2000;15:41-45.) 
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MATERIALS & METHODS 
 
In our study 60 subjects was chosen (Group A-Weaning from mechanical 
ventilation after PSV & Group B- Weaning from mechanical ventilation 
after T Piece ventilation) 
 
INCLUSION CRITERIA: 
 
• Age         : 18 years to 60 yrs 
• ASA         : I,II,III 
• Abdominal surgery cases 
• Post op cases not extubated on table 
• Patients require post op invasive ventilation atleast for 12 hrs 
• Who have given valid informed consent. 
EXCLUSION CRITERIA: 
• Not satisfying inclusion criteria. 
• Patients with difficult airway 
• Lack of written informed consent 
• Pregnant female 
• Bleeding disorder 
• Poor lung compliance such as pulmonary fibrosis 
• Patient refusal. 
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• Patients with severe cardiovascular ,respiratory, renal, 
hepatic diseases. 
• Post-Cardiac arrest patients 
Materials: 
• Mechanical ventilator 
• T-Piece circuit 
• ABG Analyser 
• Monitors – ECG, NIBP, SPO2, EtCO2. 
 
STUDY OUTCOME MEASURES: 
 
• Successful spontaneous breathing trial 
• Successful extubation 
• Extubation failure 
• Inspired oxygen fraction (FiO2) 
• Partial arterial oxygen pressure (PaO2) 
• CO2 pressure arterial (PaCO2) 
•  Length of PACU stay 
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                             METHODOLOGY OF STUDY 
 
This study was done at the Institute of Anaesthesiology and critical 
care, Madras Medical College between March to September 2017. The 
aim of this study is to  evaluate the effectiveness and safety of two 
strategies, pressure support ventilation (PSV) and spontaneous breathing 
trial with T piece, for weaning adult patients undergone upper abdominal 
surgeries who  required post operative elective mechanical ventilation for 
at least 12 hours, measuring weaning success and other clinically 
important outcomes. Patients were excluded if they have difficult airway, 
Pregnant female, Bleeding disorder, Poor lung compliance such as 
pulmonary fibrosis, Patients with severe cardiovascular, respiratory, 
renal, hepatic diseases, Post-Cardiac arrest  patients. Patients were 
randomly allocated according to the computer generated sequence into 
two equal groups. There were no difference between Group A(PSV= 30 
patients) and  the group B(T-piece =30 patients) before connecting the 
patient to mechanical ventilator. Patients in both the groups connected to 
mechanical ventilator were in assisted controlled mode of ventilation  
( Volume control ) with Fio2-100% in a paralysed state after receiving 
from operation theatre. Baseline HR, SBP, DBP, ETCO2, SPO2 
monitored. Baseline ABG sent. Analgesia with elastomeric continuous 
epidural infusion pump 5ml/hr (0.125 %  Bupivacaine and 1mcg of 
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Fentanyl )started. Patient weaned to VcSIMV mode of ventilation when 
patient improved and started taking some spontaneous breathing efforts. 
When patient is taking spontaneous breathing at a regular interval with a 
normal rate, patients were weaned to CPAP-PSV mode of ventilation 
with PS-15cm H2O. 
Then, first group of patients are maintained in CPAP-PSV mode, 
but Pressure support is decreased gradually from 15cmH2O to 12cmH2O, 
then 10cmH2O, again to 8 cmH2O, patient observed Spontaneous 
breathing trial with CPAP-PSV mode with pressure support of 8cmH2O, 
analysed with hemodynamic monitoring and ABG, patient is extubated.  
In the second group , patients changed from CPAP-PSV with  
Pressure support 15cm H2O to Spontaneous breathing trial with T-Piece 
with 6 Litres of O2/min, then the patient observed analysed with 
hemodynamic monitoring and ABG, patient is extubated.  
Both the groups were compared 
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CONTINUOUS EPIDURAL INFUSION PUMP
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Ethical Committee Approval 
 
Patient Satisfying Inclusion Criteria 
 
Informed Consent Obtained 
 
Randomization by Closed Envelope Method 
 
Patient received in PACU from OT in paralysed state 
 
Connected to Mechanical Ventilator in VcACMV Mode 
 
Weaned to VcSIMV mode 
 
Weaned to CPAP with PS 15cm H2O 
 
 
 
 
 
 
 
Extubation 
 
Measurement of Other Study Outcomes 
 
Data Compilation 
 
Statistical Analysis 
 
Conclusion 
CPAP with PSV 10cm H2O 
& 8cm H2O 
T Piece ventilation with  
6 Ltr of O2/min 
Spontaneous  
Breathing Trial 
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STATISTICAL ANALYSIS 
DATA ANALYSIS 
The collected data were analysed with IBM.SPSS statistics 
software 23.0 Version.To describe about the data descriptive statistics 
frequency analysis, percentage analysis were used for categorical 
variables and the mean & S.D were used for continuous variables. To find 
the significant difference between the bivariate samples in Paired groups 
the Paired sample t-test was used & for Independent groups the Unpaired 
sample t-test was used. To find the significance in categorical data Chi-
Square test and Fisher's Exact was used. In all the above statistical tools 
the probability value .05 is considered as significant level 
 
t tests - Means: Difference between two independent means  
(two groups) Analysis: A priori: Compute required sample size Input: 
Tail(s) = Two Effect size d = 0.74 α err prob = 0.05 Power (1-β err prob) 
= 0.8 Allocation ratio N2/N1 = 1 Output: Noncentrality parameter δ = 
2.8660077 Critical t = 2.0017175 Df = 58 Sample size group 1 = 30 
Sample size group 2 = 30 Total sample size = 60 Actual power = 
0.8046348 
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DEMOGRAPHICS 
 
 
 
 
 
 
 
 
CPAP - PSV T-Piece with O2- 6L/min 
Female 40.0% 23.3% 
Male 60.0% 76.7% 
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Sex groups 
 
Crosstab 
  
Groups 
Total 
CPAP- 
PSV 
T-Piece 
with 
O2- 
6L/min 
SEX F Count 12 7 19 
% within 
Groups 
40.0% 23.3% 31.7% 
M Count 18 23 41 
% within 
Groups 
60.0% 76.7% 68.3% 
Total Count 30 30 60 
% within 
Groups 
100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 1.926
a 1 .165   
Continuity 
Correctionb 1.232 1 .267   
Likelihood 
Ratio 1.943 1 .163   
Fisher's Exact 
Test    .267 .133 
N of Valid 
Cases 60     
 
a. 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 9.50. 
b. Computed only for a 2x2 table 
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MEAN HEART RATE 
 
 
 
 
                 CPAP- PSV 
T-piece with 
O2-6L/min 
Baseline 96.27 101.47 
5 Min 96.07 99.20 
10 Min 95.97 98.90 
15 Min 94.67 96.77 
20 Min 93.53 97.17 
25 Min 92.47 95.13 
30 Min 91.90 95.23 
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MEAN SYSTOLIC BLOOD PRESSURE 
  CPAP- PSV T-piece with O2-6L/min  
Baseline 131.83 136.00  
5 Min 131.13 141.90  
10 Min 169.77 139.33  
15 Min 128.40 171.30  
20 Min 127.97 136.53  
25 Min 123.67 135.43  
30 Min 122.93 134.27  
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MEAN DIASTOLIC BLOOD PRESSURE 
 
 CPAP- PSV T-piece with  
O2-6L/min 
Baseline 81.87 92.03 
5 Min 81.13 88.40 
10 Min 81.70 87.07 
15 Min 80.23 86.33 
20 Min 79.70 85.20 
25 Min 79.37 85.10 
30 Min 79.00 83.90 
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MEAN SPO2 
 
  CPAP- PSV T-piece with O2-6L/min 
Baseline 100.00 99.57 
5 Min 100.00 99.53 
10 Min 99.97 99.73 
15 Min 99.80 99.70 
20 Min 100.00 99.80 
25 Min 99.97 99.93 
30 Min 100.00 99.87 
 
 
 
 
 
 65 
 
 
MEAN ETCO2 
  CPAP- PSV T-piece with O2-6L/min 
Baseline 35.20 38.47 
5 Min 35.63 38.60 
10 Min 35.40 38.53 
15 Min 35.87 38.43 
20 Min 36.03 38.47 
25 Min 36.20 38.33 
30 Min 36.50 38.47 
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MEAN PH 
 
   CPAP- PSV T-piece with O2-6L/min 
Baseline 7.330 7.343 
CPAP-PSV WITH 
PS 15CMH2O 7.375 7.379 
SBT WITH C 
PAP - PSV 7.379   
SBT WITH T 
Piece with O2- 
6L/min 
  7.344 
24 hrs 7.382 7.333 
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MEAN PCO2 
 
   CPAP- PSV T-piece with O2-6L/min 
Baseline 35.9 39.1 
CPAP-PSV WITH 
PS 15CMH2O 36.6 39.2 
SBT WITH C 
PAP - PSV 37.6   
SBT WITH T 
Piece with  
O2- 6L/min 
  40.4 
24 hrs 38.0 40.8 
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MEAN  PO2 
 
   CPAP- PSV T-piece with O2-6L/min 
Baseline 427.1 358.5 
CPAP-PSV WITH 
PS 15CMH2O 148.7 133.5 
SBT WITH  
CPAP - PSV 150.4   
SBT WITH T 
Piece with  
O2- 6L/min 
  112.1 
24 hrs 120.3 107.6 
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RE-INTUBATION 
 
CPAP- PSV 
T-Piece with O2- 
6L/min 
No 96.7% 73.3% 
Yes 3.3% 26.7% 
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Re-intubation Groups 
 
Crosstab 
  
Groups 
Total 
CPAP- 
PSV 
T-
Piece 
with 
O2- 
6L/min 
Re-
intubation 
N Count 29 22 51 
% within 
Groups 
96.7% 73.3% 85.0% 
Y Count 1 8 9 
% within 
Groups 
3.3% 26.7% 15.0% 
Total Count 30 30 60 
% within 
Groups 
100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. 
(2-
sided) 
Exact 
Sig. 
(1-
sided) 
Pearson 
Chi-Square 
6.405a 1 .011     
Continuity 
Correctionb 
4.706 1 .030     
Likelihood 
Ratio 
7.161 1 .007     
Fisher's 
Exact Test 
      .026 .013 
N of Valid 
Cases 
60         
 
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is 4.50. 
b. Computed only for a 2x2 table 
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Independent Samples Test 
 
  
Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
AGE Equal 
variances 
assumed 
.061 .806 2.270 58 .027 4.800 2.114 .568 9.032 
Equal 
variances 
not 
assumed 
    2.270 57.880 .027 4.800 2.114 .568 9.032 
HR 0 Equal 
variances 
assumed 
.434 .512 1.395 58 .168 5.200 3.727 -2.261 12.661 
Equal 
variances 
not 
assumed 
    1.395 55.592 .169 5.200 3.727 -2.268 12.668 
HR5 Equal 
variances 
assumed 
.342 .561 .944 58 .349 3.133 3.319 -3.511 9.777 
Equal 
variances 
not 
assumed 
    .944 55.979 .349 3.133 3.319 -3.516 9.782 
HR10 Equal 
variances 
assumed 
.063 .803 .909 58 .367 2.933 3.226 -3.524 9.391 
Equal 
variances 
not 
assumed 
    .909 57.187 .367 2.933 3.226 -3.526 9.393 
HR15 Equal 
variances 
assumed 
.014 .907 .652 58 .517 2.100 3.223 -4.352 8.552 
Equal 
variances 
not 
assumed 
    .652 57.992 .517 2.100 3.223 -4.352 8.552 
HR20 Equal 
variances 
assumed 
.064 .801 1.207 58 .232 3.633 3.011 -2.394 9.661 
Equal 
variances 
not 
assumed 
    1.207 57.391 .233 3.633 3.011 -2.395 9.662 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
HR25 Equal 
variances 
assumed 
.146 .703 .913 58 .365 2.667 2.921 -3.180 8.514 
Equal 
variances 
not 
assumed 
    .913 56.736 .365 2.667 2.921 -3.183 8.516 
HR30 Equal 
variances 
assumed 
.012 .914 1.181 58 .243 3.333 2.824 -2.319 8.985 
Equal 
variances 
not 
assumed 
    1.181 56.263 .243 3.333 2.824 -2.322 8.989 
SBP0 Equal 
variances 
assumed 
9.952 .003 .821 58 .415 4.167 5.076 -5.994 14.327 
Equal 
variances 
not 
assumed 
    .821 41.986 .416 4.167 5.076 -6.077 14.411 
SBP5 Equal 
variances 
assumed 
1.535 .220 2.812 58 .007 10.767 3.829 3.102 18.431 
Equal 
variances 
not 
assumed 
    2.812 47.995 .007 10.767 3.829 3.068 18.465 
SBP10 Equal 
variances 
assumed 
3.080 .085 -.754 58 .454 -30.433 40.376 -111.255 50.388 
Equal 
variances 
not 
assumed 
    -.754 29.377 .457 -30.433 40.376 -112.966 52.099 
SBP15 Equal 
variances 
assumed 
3.689 .060 1.283 58 .205 42.900 33.436 -24.030 109.830 
Equal 
variances 
not 
assumed 
    1.283 29.145 .210 42.900 33.436 -25.470 111.270 
SBP20 Equal 
variances 
assumed 
1.217 .275 2.753 58 .008 8.567 3.111 2.338 14.795 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Equal 
variances 
not 
assumed 
    2.753 51.653 .008 8.567 3.111 2.322 14.811 
SBP25 Equal 
variances 
assumed 
3.230 .078 -.767 58 .446 -28.233 36.823 -101.943 45.477 
 
 
 
Equal 
variances 
not 
assumed 
    -.767 29.288 .449 -28.233 36.823 -103.513 47.047 
SBP30 Equal 
variances 
assumed 
3.312 .074 -.779 58 .439 -28.667 36.794 -102.317 44.984 
Equal 
variances 
not 
assumed 
    -.779 29.269 .442 -28.667 36.794 -103.888 46.555 
DBP0 Equal 
variances 
assumed 
.054 .817 3.577 58 .001 10.167 2.842 4.477 15.856 
Equal 
variances 
not 
assumed 
    3.577 56.066 .001 10.167 2.842 4.473 15.860 
DBP5 Equal 
variances 
assumed 
.030 .862 2.753 58 .008 7.267 2.639 1.983 12.550 
Equal 
variances 
not 
assumed 
    2.753 57.373 .008 7.267 2.639 1.982 12.551 
DBP10 Equal 
variances 
assumed 
.000 .990 2.076 58 .042 5.367 2.585 .192 10.541 
Equal 
variances 
not 
assumed 
    2.076 57.410 .042 5.367 2.585 .191 10.543 
DBP15 Equal 
variances 
assumed 
.087 .769 2.248 58 .028 6.100 2.714 .667 11.533 
Equal 
variances 
    2.248 56.639 .029 6.100 2.714 .665 11.535 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
not 
assumed 
DBP20 Equal 
variances 
assumed 
.002 .962 2.240 58 .029 5.500 2.455 .585 10.415 
Equal 
variances 
not 
assumed 
    2.240 57.912 .029 5.500 2.455 .585 10.415 
DBP25 Equal 
variances 
assumed 
.094 .760 2.456 58 .017 5.733 2.334 1.061 10.405 
Equal 
variances 
not 
assumed 
    2.456 57.068 .017 5.733 2.334 1.060 10.407 
DBP30 Equal 
variances 
assumed 
.152 .698 2.217 58 .031 4.900 2.210 .475 9.325 
Equal 
variances 
not 
assumed 
    2.217 55.644 .031 4.900 2.210 .471 9.329 
SPO20 Equal 
variances 
assumed 
48.480 .000 2.904 58 .005 .433 .149 .135 .732 
Equal 
variances 
not 
assumed 
    2.904 29.000 .007 .433 .149 .128 .738 
SPO25 Equal 
variances 
assumed 
36.796 .000 2.626 58 .011 .467 .178 .111 .822 
Equal 
variances 
not 
assumed 
    2.626 29.000 .014 .467 .178 .103 .830 
SPO210 Equal 
variances 
assumed 
21.753 .000 2.091 58 .041 .233 .112 .010 .457 
Equal 
variances 
not 
assumed 
    2.091 34.628 .044 .233 .112 .007 .460 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
SPO215 Equal 
variances 
assumed 
4.284 .043 1.001 58 .321 330.267 330.001 -330.302 990.836 
Equal 
variances 
not 
assumed 
    1.001 29.000 .325 330.267 330.001 -344.662 1005.195 
SPO220 Equal 
variances 
assumed 
27.885 .000 2.262 58 .027 .200 .088 .023 .377 
Equal 
variances 
not 
assumed 
    2.262 29.000 .031 .200 .088 .019 .381 
SPO225 Equal 
variances 
assumed 
1.396 .242 .584 58 .561 .033 .057 -.081 .148 
Equal 
variances 
not 
assumed 
    .584 52.684 .562 .033 .057 -.081 .148 
SPO230 Equal 
variances 
assumed 
13.404 .001 1.682 58 .098 .133 .079 -.025 .292 
 
 
 
Equal 
variances 
not 
assumed 
    1.682 29.000 .103 .133 .079 -.029 .295 
ETCO20 Equal 
variances 
assumed 
3.440 .069 -2.948 58 .005 -3.267 1.108 -5.485 -1.049 
Equal 
variances 
not 
assumed 
    -2.948 54.725 .005 -3.267 1.108 -5.488 -1.046 
ETCO25 Equal 
variances 
assumed 
.745 .392 -2.680 58 .010 -2.967 1.107 -5.183 -.751 
Equal 
variances 
not 
assumed 
    -2.680 56.726 .010 -2.967 1.107 -5.184 -.750 
ETCO210 Equal 
variances 
.667 .417 -2.988 58 .004 -3.133 1.049 -5.232 -1.034 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
assumed 
Equal 
variances 
not 
assumed 
    -2.988 57.076 .004 -3.133 1.049 -5.233 -1.034 
ETCO215 Equal 
variances 
assumed 
.968 .329 -2.763 58 .008 -2.567 .929 -4.426 -.707 
Equal 
variances 
not 
assumed 
    -2.763 57.140 .008 -2.567 .929 -4.427 -.706 
ETCO220 Equal 
variances 
assumed 
.096 .758 -2.772 58 .007 -2.433 .878 -4.191 -.676 
Equal 
variances 
not 
assumed 
    -2.772 57.710 .007 -2.433 .878 -4.191 -.676 
ETCO225 Equal 
variances 
assumed 
.296 .588 -2.670 58 .010 -2.133 .799 -3.733 -.534 
Equal 
variances 
not 
assumed 
    -2.670 57.189 .010 -2.133 .799 -3.733 -.533 
ETCO230 Equal 
variances 
assumed 
.044 .835 -2.499 58 .015 -1.967 .787 -3.542 -.391 
Equal 
variances 
not 
assumed 
    -2.499 57.885 .015 -1.967 .787 -3.542 -.391 
FIO2 B Equal 
variances 
assumed 
4.291 .043 1.000 58 .321 2.000 2.000 -2.003 6.003 
Equal 
variances 
not 
assumed 
    1.000 29.000 .326 2.000 2.000 -2.090 6.090 
PH B Equal 
variances 
assumed 
1.619 .208 -2.629 58 .011 -.043667 .016609 -.076912 -.010421 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Equal 
variances 
not 
assumed 
    -2.629 51.429 .011 -.043667 .016609 -.077003 -.010330 
PCO2 B Equal 
variances 
assumed 
2.980 .090 -2.524 58 .014 -3.2733 1.2968 -5.8692 -.6774 
Equal 
variances 
not 
assumed 
    -2.524 53.749 .015 -3.2733 1.2968 -5.8736 -.6731 
PO2 B Equal 
variances 
assumed 
2.914 .093 3.726 58 .000 68.600 18.412 31.744 105.456 
Equal 
variances 
not 
assumed 
    3.726 55.096 .000 68.600 18.412 31.702 105.498 
PH CPAP-
PSV WITH 
PS 
15CMH2O 
Equal 
variances 
assumed 
7.171 .010 -.339 58 .736 -.003467 .010234 -.023952 .017019 
Equal 
variances 
not 
assumed 
    -.339 45.917 .736 -.003467 .010234 -.024067 .017134 
PCO2 
CPAP-PSV 
WITH PS 
15CMH2O 
Equal 
variances 
assumed 
20.768 .000 -2.725 58 .008 -2.6267 .9641 -4.5565 -.6968 
Equal 
variances 
not 
assumed 
    -2.725 37.726 .010 -2.6267 .9641 -4.5788 -.6745 
PO2 CPAP-
PSV WITH 
PS 
15CMH2O 
Equal 
variances 
assumed 
.015 .904 3.483 58 .001 15.233 4.373 6.480 23.987 
Equal 
variances 
not 
assumed 
    3.483 56.291 .001 15.233 4.373 6.474 23.993 
FIO2 24 Equal 
variances 
assumed 
31.605 .000 -2.344 58 .023 -3.80000 1.62110 -7.04499 -.55501 
 
 
 
Equal 
variances 
    -2.344 39.119 .024 -3.80000 1.62110 -7.07867 -.52133 
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Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
not 
assumed 
PH 24 Equal 
variances 
assumed 
.381 .540 .531 58 .597 .003967 .007469 -.010984 .018918 
Equal 
variances 
not 
assumed 
    .531 55.903 .597 .003967 .007469 -.010996 .018930 
PCO2 24 Equal 
variances 
assumed 
2.860 .096 -3.321 58 .002 -2.7800 .8371 -4.4555 -1.1045 
Equal 
variances 
not 
assumed 
    -3.321 55.740 .002 -2.7800 .8371 -4.4570 -1.1030 
PO2 24 Equal 
variances 
assumed 
1.928 .170 4.116 58 .000 12.700 3.085 6.524 18.876 
Equal 
variances 
not 
assumed 
    4.116 55.044 .000 12.700 3.085 6.517 18.883 
Duration of 
MV 
Equal 
variances 
assumed 
3.159 .081 -3.980 58 .000 -386.700 97.150 -581.168 -192.232 
Equal 
variances 
not 
assumed 
    -3.980 46.078 .000 -386.700 97.150 -582.245 -191.155 
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GROUP STATISTICS 
 
Groups N Mean Std. Deviation 
Std. 
Error 
Mean 
AGE C PAP- PSV 30 51.63 8.373 1.529 
T-Piece 30 46.83 8.000 1.461 
HR 0 T-Piece 30 101.47 15.867 2.897 
C PAP- PSV 30 96.27 12.846 2.345 
HR5 T-Piece 30 99.20 14.023 2.560 
C PAP- PSV 30 96.07 11.570 2.112 
HR10 T-Piece 30 98.90 13.218 2.413 
C PAP- PSV 30 95.97 11.725 2.141 
HR15 T-Piece 30 96.77 12.555 2.292 
C PAP- PSV 30 94.67 12.411 2.266 
HR20 T-Piece 30 97.17 12.248 2.236 
C PAP- PSV 30 93.53 11.045 2.016 
HR25 T-Piece 30 95.13 12.128 2.214 
C PAP- PSV 30 92.47 10.434 1.905 
HR30 T-Piece 30 95.23 11.857 2.165 
C PAP- PSV 30 91.90 9.929 1.813 
SBP0 T-Piece 30 136.00 25.003 4.565 
C PAP- PSV 30 131.83 12.157 2.220 
SBP5 T-Piece 30 141.90 17.897 3.268 
C PAP- PSV 30 131.13 10.932 1.996 
SBP10 T-Piece 30 139.33 17.773 3.245 
C PAP- PSV 30 169.77 220.433 40.245 
SBP15 T-Piece 30 171.30 182.909 33.395 
C PAP- PSV 30 128.40 9.160 1.672 
SBP20 T-Piece 30 136.53 14.004 2.557 
C PAP- PSV 30 127.97 9.711 1.773 
SBP25 T-Piece 30 135.43 14.178 2.589 
C PAP- PSV 30 123.67 9.102 36.732 
SBP30 T-Piece 30 134.27 13.696 2.501 
C PAP- PSV 30 122.93 9.078 36.709 
DBP0 T-Piece 30 92.03 11.987 2.189 
C PAP- PSV 30 81.87 9.933 1.814 
DBP5 T-Piece 30 88.40 10.743 1.961 
C PAP- PSV 30 81.13 9.673 1.766 
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Groups N Mean Std. Deviation 
Std. 
Error 
Mean 
DBP10 T-Piece 30 87.07 10.508 1.918 
C PAP- PSV 30 81.70 9.491 1.733 
DBP15 T-Piece 30 86.33 11.296 2.062 
C PAP- PSV 30 80.23 9.662 1.764 
DBP20 T-Piece 30 85.20 9.693 1.770 
C PAP- PSV 30 79.70 9.322 1.702 
DBP25 T-Piece 30 85.10 9.600 1.753 
C PAP- PSV 30 79.37 8.442 1.541 
DBP30 T-Piece 30 83.90 9.400 1.716 
C PAP- PSV 30 79.00 7.629 1.393 
SPO20 C PAP- PSV 30 100.00 0.000 0.000 
T-Piece 30 99.57 .817 .149 
SPO25 C PAP- PSV 30 100.00 0.000 0.000 
T-Piece 30 99.53 .973 .178 
SPO210 C PAP- PSV 30 99.97 .183 .033 
T-Piece 30 99.73 .583 .106 
SPO215 C PAP- PSV 30 99.80 0.484 0.088 
T-Piece 30 99.70 .651 .119 
SPO220 C PAP- PSV 30 100.00 0.000 0.000 
T-Piece 30 99.80 .484 .088 
SPO225 C PAP- PSV 30 99.97 .183 .033 
T-Piece 30 99.93 .254 .046 
SPO230 C PAP- PSV 30 100.00 0.000 0.000 
T-Piece 30 99.87 .434 .079 
ETCO20 C PAP- PSV 30 35.20 4.788 .874 
T-Piece 30 38.47 3.730 .681 
ETCO25 C PAP- PSV 30 35.63 4.597 .839 
T-Piece 30 38.60 3.953 .722 
ETCO210 C PAP- PSV 30 35.40 4.312 .787 
T-Piece 30 38.53 3.794 .693 
ETCO215 C PAP- PSV 30 35.87 3.812 .696 
T-Piece 30 38.43 3.370 .615 
ETCO220 C PAP- PSV 30 36.03 3.518 .642 
T-Piece 30 38.47 3.277 .598 
ETCO225 C PAP- PSV 30 36.20 3.274 .598 
T-Piece 30 38.33 2.905 .530 
ETCO230 C PAP- PSV 30 36.50 3.116 .569 
T-Piece 30 38.47 2.980 .544 
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Groups N Mean Std. Deviation 
Std. 
Error 
Mean 
FIO2 B C PAP- 
PSV 
30 100.00 0.000 0.000 
T-Piece 30 98.00 10.954 2.000 
PH B C PAP- 
PSV 
30 7.33047 .074944 .013683 
T-Piece 30 7.37413 .051563 .009414 
PCO2 B C PAP- 
PSV 
30 35.853 5.6852 1.0380 
T-Piece 30 39.127 4.2582 .7774 
PO2 B C PAP- 
PSV 
30 427.13 62.592 11.428 
T-Piece 30 358.53 79.074 14.437 
FIO2 
CPAP-PSV 
WITH PS 
15CMH2O 
C PAP- 
PSV 
30 40.000 .0000a 0.0000 
T-Piece 
30 40.000 .0000a 0.0000 
PH CPAP-
PSV WITH 
PS 
15CMH2O 
C PAP- 
PSV 
30 7.37537 .048753 .008901 
T-Piece 
30 7.37883 .027661 .005050 
PCO2 
CPAP-PSV 
WITH PS 
15CMH2O 
C PAP- 
PSV 
30 36.580 4.9155 .8974 
T-Piece 
30 39.207 1.9291 .3522 
PO2 
CPAP-PSV 
WITH PS 
15CMH2O 
C PAP- 
PSV 
30 148.70 18.353 3.351 
T-Piece 
30 133.47 15.391 2.810 
FIO2 24 C PAP- 
PSV 
30 21.6333 3.46891 .63333 
T-Piece 30 25.4333 8.17348 1.49227 
PH 24 C PAP- 
PSV 
30 7.38153 .025976 .004743 
T-Piece 30 7.37757 .031605 .005770 
PCO2 24 C PAP- 
PSV 
30 38.047 3.5533 .6487 
T-Piece 30 40.827 2.8972 .5290 
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Groups N Mean Std. Deviation 
Std. 
Error 
Mean 
 
 
PO2 24 C PAP- 
PSV 
30 120.30 13.262 2.421 
T-Piece 30 107.60 10.474 1.912 
Duration of 
MV 
C PAP- 
PSV 
30 19.2 4.390   
T-Piece 30 25.3 8.100   
 
a. t cannot be computed because the standard deviations of both groups 
are 0. 
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DURATION OF MECHANICAL VENTILATION 
 
Groups N Mean Std. Deviation 
Std. 
Error 
Mean 
Duration 
of MV 
C PAP- PSV 30 19.2 9.67665   
T-Piece 30 25.3 18.100   
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Descriptive 
 
 
Groups = CPAP- PSV 
 
 
Descriptive Statisticsa 
 
  N Minimum Maximum Mean 
Std. 
Deviation 
FIO2  SBT 
WITH C 
PAP - PSV 
30 40.0 40.0 40.000 0.0000 
PH SBT 
WITH C 
PAP - PSV 
30 7.361 7.450 7.41947 .034567 
PCO2 SBT 
WITH C 
PAP - PSV 
30 37.1 44.86 41.567 4.7324 
PO2 SBT 
WITH C 
PAP - PSV 
30 125 193 150.43 9.195 
 
a. Groups = C PAP- PSV 
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Descriptive Statisticsa 
Groups = T-Piece with O2- 6L/min 
 
 
 N Minimum Maximum Mean 
Std. 
Deviation 
FIO2 
SBT 
WITH T 
Piece 
with O2- 
6L/min 
30 28.00 28.00 28.0000 0.00000 
PH SBT 
WITH T 
Piece 
with O2- 
6L/min 
30 7.322 7.432 7.36940 12.16714 
PCO2 
SBT 
WITH T 
Piece 
with O2- 
6L/min 
30 33.40 49.10 46.4033 9.67665 
PO2 SBT 
WITH T 
Piece 
with O2- 
6L/min 
30 82 126 112.07 16.858 
a. Groups = T-piece with O2- 6L/min 
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DISCUSSION 
A prospective randomised controlled study to compare the efficacy 
and safety of Weaning of adult patients by T piece ventilation and 
pressure support ventilation in PACU who have undergone elective upper 
abdominal surgeries   
CPAP-PSV :  
It is PEEP applied to the airway of the Spontaneously breathing 
patients. Pressure support ventilation is used to reduce the elastic and non 
elastic airflow resistance, to augment the spontaneous tidal volume. 
Resulting spontaneous tidal volume is directly proportional to the 
pressure support level. It helps in improving oxygenation in patients with 
refractory hypoxemia and a low FRC.  CPAP settings are adjusted to 
provide the better oxygenation with the lowest positive pressure and the 
lowest FiO2 
Advantages : 
• Ventilator can monitor the patient’s breathing and activate an alarm 
if something undesirable occurs 
 
 
 87 
 
T-piece with O2 -  6L/min 
T-piece assist in weaning a patient from ventilator. T Piece deliver 
humidified oxygen to a long term ventilated patient who is being weaned 
from ventilator. In T piece inhaled gas is delivered at a high flow rate 
In our study the demographic profile was comparable with the respective 
mean age, body weight and ASA physical status. Patients were 
randomised into two groups, group-A weaned and extubated after CPAP-
PSV and group-B weaned and extubated after T-piece with O2-6L/min. 
Hemodynamic parameters like heart rate, systolic, diastolic blood 
pressure, EtCO2, ABG, time to wean, extubation failure, Reintubation, 
were monitored.  
1. Patients in group-A have a stable heart rate compared with group – B 
having increased in heart rate in the process of weaning and 
observation during post extubation period for 24 hrs. This difference 
in diastolic blood or 24 hrs. This difference in heart rate between the 
two groups was statistically significant(p<0.05).  
2. Patients in group-A have a normal range of  systolic blood pressure 
compared with group-B having increased systolic blood pressure 
during weaning from ventilator and observation during post 
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extubation period for 24 hrs. This difference in systolic blood pressure 
between the two groups was statistically significant(p<0.05).  
3. Patients in group-A have a normal range of  diastolic blood pressure 
compared with group-B having increased diastolic blood pressure 
during weaning from ventilator and observation during extubation 
period for 24 hrs. This difference in systolic blood pressure between 
the two groups was statistically significant(p<0.05).   
4. Patients in group-A have a good saturation (>99%)compared with 
group-B having low saturation (<99%) during weaning from ventilator 
and observation during post extubation period for 24 hrs. This 
difference in saturation between the two groups was statistically 
significant(p<0.05).  
5. Patients in group-A have a normal range of  ETCO2 compared with 
group-B having increased ETCO2 during weaning from ventilator and 
observation during post extubation period for 24 hrs. This difference 
in ETCO2 between the two groups was statistically 
significant(p<0.05).  
6. Patients in group-A have a less spontaneous breathing trial failure 
compared with group-B having high spontaneous breathing trial 
failure during weaning from ventilator . This difference in 
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spontaneous breathing trial failure between the two groups was 
statistically significant(p<0.05).  
7. Patients in group-A have a normal range of  PH compared with group-
B  moving towards acidotic side during weaning from ventilator and 
observation during post extubation period for 24 hrs. The results were 
Mean PH in group A was 7.41947 with SD of 0.034567 and in group 
B mean PH was 7.36940 with SD of 12.09  which was found to be 
statistically significant.This difference in PH between the two groups 
was statistically significant(p<0.05) 
8. Patients in group-A have a normal range of  PaO2 compared with 
group-B having decreased PaO2 during weaning from ventilator and 
observation during post extubation period for 24 hrs. The results were 
Mean PaO2 in group A was 150.43 with SD of 9.195and in group B 
mean PaO2 was 112.07 with SD of 16.858  which was found to be 
statistically significant. This difference in PaO2 between the two 
groups was statistically significant(p<0.05) 
9. Patients in group-A have a normal range of  PaCO2 compared with 
group-B having increased PaCO2 during weaning from ventilator and 
observation during post extubation period for 24 hrs. The results were 
Mean PaCO2 in group A was 41.5667 with SD of 4.7324and in group 
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B mean PaCO2 was 46.4033 with SD of 9.67665  which was found to 
be statistically significant This difference in PaCO2 between the two 
groups was statistically significant(p<0.05) 
10. Patients in group-A have less duration of mechanical ventilation and 
had early extubation compared with group-B having increased 
duration of mechanical ventilation and delayed extubation. The results 
were Mean duration of MV in group A was 19.2 hours with SD of 
9.67665 and in group B mean PH was 25.3 hours SD of 18.100 which 
was found to be statistically significant. This difference in duration of 
mechanical ventilation between the two groups was statistically 
significant(p<0.05) 
11. Patients in group-A have a very less incidence of Reintubation 
compared with group-B having increased incidence of Reintubation 
during  post extubation period for 24 hrs. The results were Mean 
reintubation in group A was 3.3% with SD 3.561  and in group B 
mean reitubation was 26.6% with SD 17.2234 which was found to be 
statistically significant This difference in Reintubation between the 
two groups was statistically significant(p<0.05) 
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SUMMARY 
  
Weaning is a process of withdrawing mechanical ventilator support and 
transferring work of breathing from mechanical ventilator to patient. 
This study was conducted to evaluate the effectiveness and safety of two 
strategies, a pressure support ventilation (PSV) and spontaneous 
breathing trial with T piece, for weaning adult patients undergone upper 
abdominal surgeries who  required post operative elective mechanical 
ventilation for at least 12 hours, measuring weaning success and other 
clinically important outcomes.  
The following observations were made:  
 Mean heart rate was lower in PSV group than T piece group which 
was statistically significant.  
 Mean systolic blood pressure was lower in PSV group than T piece 
group which was statistically significant.  
 Mean diastolic blood pressure was lower in PSV group than T 
piece group which was statistically significant.   
 Mean SPO2 was better in PSV group than T piece group which 
was statistically significant.  
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 Mean ETCO2 was lower in PSV group than T piece group which 
was statistically significant.  
 Mean PH was better in PSV group than T piece group which was 
statistically significant.  
 Mean PaO2 was higher in PSV group than T piece group which 
was statistically significant.  
 Mean PaCO2 was lower in PSV group than T piece group which 
was statistically significant.  
 Mean duration of Mechanical ventilation  was lower in PSV group 
than T piece group which was statistically significant.  
 Reintubation was lower in PSV group than T piece group which 
was statistically significant.  
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CONCLUSION  
 
From my study, I conclude that weaning the patients from mechanical 
ventilator who have undergone upper abdominal surgeries can be done by 
Pressure support ventilation or by T piece with O2-6L/min. Considering 
the better hemodynamic stability, gas analysis, less duration of 
mechanical ventilation, lesser incidence of reintubation, I conclude 
pressure support ventilation is superior in weaning the patient from 
mechanical ventilator than T-piece ventilation 
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     ANNEXURES 
PROFORMA 
Date : 
Name : 
Age/Sex : 
IP No : 
Diagnosis : 
Surgical Procedure Done : 
Co morbid Illness : 
Duration of Surgery : 
Reason for EPOV : 
Patient received in PACU and connected to VcACMV 
Events/  
Time (min) 0 5 10 15 20 25 30 
HR        
SBP        
DBP        
SPO2        
ETCO2        
Baseline Gas Changes after connecting to Ventilator with  
FIO2–100% 
PH PCO2 HCO3– PO2 SO2 
     
Gas values in CPAP with PSV 15cm of H2O 
PH PCO2 HCO3– PO2 SO2 
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SPONTANEOUS BREATHING TRIAL 
Comparison of CPAP–PSV and ‘T’ Piece Ventilation 
Events/ 
Time 
(min) 
0 5 10 15 20 25 30 35 40 45 50 55 60 
HR              
SBP              
DBP              
SPO2              
RR              
PH              
PO2              
PCO2              
POST EXTUBATION MONITORING 
Comparison of CPAP–PSV and ‘T’ Piece Ventilation 
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INFORMATION TO PARTICIPANTS 
Investigator                      :       Dr. Gopinath.A   
Name of the Participant: 
Title.  “Pressure support versus spontaneous breathing trial with ‘T’ 
piece for weaning from mechanical ventilation in adults in Post 
anaesthesia care unit(PACU)”. 
 
  
(A Prospective, randomized study for evaluating  the effectiveness and 
safety of two strategies, a pressure support ventilation (PSV) and ‘T’ tube 
ventilation for weaning adult patients) 
 
You are invited to take part in this research study. We have got approval 
from the IEC. You are asked to participate because you satisfy the 
eligibility criteria. We want to evaluate the effectiveness and safety of 
two strategies, a pressure support ventilation (PSV) and ‘T’ tube 
ventilation for weaning adult patients that required mechanical ventilation 
for at least 12 hours, measuring weaning success and other clinically 
important outcomes. 
What is the Purpose of the Research: 
For Mechanically ventilated patients, in PACU, pressure support and  
T-Piece ventilation are compared for weaning and to study 
 
The Study Design: 
All the patients in the study will be divided into two groups. 
60 patients requiring post operative mechanical ventilation were 
randomly assigned to two groups . 
1 . Total duration of MV (days or hours). 
2.  Time of weaning from MV or weaning duration 
3.  Hemodynamic & Biochemical changes related to weaning 
 4.  PACU- Length of stay. 
 5.  Proportion requiring Re-intubation 
 6.  Mortality 
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GroupA-Weaning from mechanical ventilation from pressure support 
ventilation 
 
Group B- Weaning from mechanical ventilation from T Piece ventilation 
 
Benefits 
PSV was more effective than a T-piece for successful spontaneous 
breathing trials (SBTs) and Weaning duration is shorter with pressure 
support ventilation comparing with T-Piece                      
 
Discomforts and risks 
Extubaion failure 
Chances of Re-intubation 
This intervention has been shown to be well tolerated as shown by 
previous studies. And if you do not want to participate you will have 
alternative of setting the standard treatment and your safety is our prime 
concern. 
Time : 
Date : 
Place : 
 
Signature / Thumb Impression of Patient 
Patient Name: 
 
Signature of the Investigator : ____________________________ 
Name of the Investigator  : ____________________________ 
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PATIENT CONSENT FORM 
Study title     “Pressure support versus spontaneous breathing trial 
with ‘T’ piece for weaning from mechanical ventilation in adults in 
Post anaesthesia care unit(PACU)”. 
. 
 (A Prospective, randomized, study for evaluating  the effectiveness and 
safety of two strategies, a pressure support ventilation (PSV) and ‘T’ tube 
ventilation for weaning adult patients) 
 
 
Study center:  INSTITUTE OF ANAESTHESIOLOGY AND 
CRITICAL CARE, 
 RAJIV GANDHI GOVT. GENERAL HOSPITAL, 
MADRAS MEDICAL COLLEGE, 
CHENNAI-03. 
 
Participant name:                                                Age:                         Sex:                                
I.P.No: 
 
 
I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask the question and all my 
questions and doubts have been answered to my satisfaction. 
 
I have been explained about the pitfall in the procedure.  I have 
been explained about the safety, advantage and disadvantage of the 
technique. 
 
I understand that my participation in the study is voluntary and that 
I am free to withdraw at anytime without giving any reason. 
 
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both 
in respect to current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study. I understand that my 
identity will not be revealed in any information released to third parties or 
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published, unless as required under the law. I agree not to restrict the use 
of any data or results that arise from the study. 
 
Time:          
 
Date:                                                                                             Signature 
/ thumb impression of patient  
 
Place:                                                                                            Patient 
name: 
 
Signature of the investigator: 
 
Name of the investigator: 
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